Department of Plastic and Breast Surgery, Aarhus University Hospital, Aarhus, Denmark.
Department of Experimental Clinical Oncology, Aarhus University Hospital, Aarhus, Denmark.
Acta Oncol. 2021 Jun;60(6):750-759. doi: 10.1080/0284186X.2021.1900907. Epub 2021 Mar 31.
Few studies have focused on the symptoms of loco-regional morbidity in shoulders, arms, and breasts related to oncoplastic breast surgery (OPS). This study aimed to determine if a difference exists in the prevalence or variety of subjective symptoms of shoulder, arm, and breast morbidity in patients undergoing OPS compared with patients receiving conventional breast conserving surgery (C-BCS). Cosmetic result and body image were included as secondary endpoints. This prospective follow-up study with 18 months of questionnaire-based follow-up included women with breast cancer or ductal carcinoma . They were divided into two groups - C-BCS or OPS - depending on type of surgery performed. Furthermore, patient, disease, and treatment characteristics were recorded. Among 334 completers, 229 (69%) received C-BCS and 105 (31%) received OPS. Participants were comparable regarding age, comorbidity, BMI, re-excision rate (15-16%), and axillary surgery. As for tumor characteristics, a more advanced disease stage was shown in the OPS than in the C-BCS group with larger tumor and lumpectomy size, more multifocality, and the corresponding following systemic adjuvant therapy.The questionnaire revealed that the two groups were comparable with no significant differences in frequency or variety of symptoms of shoulder and arm morbidity. Overall, participants were highly satisfied with the cosmetic results in both groups and no significant inter-group differences were observed. In patients with larger tumors, breast conserving surgery utilizing oncoplastic techniques yields results regarding subjective shoulder, arm, and breast morbidity as well as cosmetic outcome comparable with those of C-BCS performed on smaller tumors. ClinicalTrials.gov, registration number: NCT02159274 (2014).HIGHLIGHTSSubjective symptoms of shoulder, arm, and breast morbidity are comparable when oncoplastic breast surgery is compared to conventional breast conserving surgery.The variety of symptoms of shoulder and arm morbidity following oncoplastic surgery does not differ from symptoms following conventional breast conserving surgery.The cosmetic outcome following oncoplastic breast surgery is comparable to breast conserving surgery without oncoplastic techniques.
鲜有研究关注与肿瘤整形保乳手术(OPS)相关的肩部、手臂和乳房局部发病率的症状。本研究旨在确定与接受传统保乳手术(C-BCS)的患者相比,接受 OPS 的患者在肩部、手臂和乳房发病率的主观症状的发生率或种类是否存在差异。美容效果和身体形象被包括为次要终点。这是一项前瞻性随访研究,采用基于问卷的随访 18 个月,纳入乳腺癌或导管癌患者。根据所行手术类型将她们分为 C-BCS 或 OPS 两组。此外,还记录了患者、疾病和治疗特征。在 334 名完成者中,229 名(69%)接受了 C-BCS,105 名(31%)接受了 OPS。两组在年龄、合并症、BMI、再次切除率(15-16%)和腋窝手术方面具有可比性。在肿瘤特征方面,OPS 组的疾病分期较 C-BCS 组更晚,肿瘤和肿瘤切除术尺寸更大,多灶性更多,相应的后续全身性辅助治疗也更多。问卷调查显示,两组在肩部和手臂发病率的症状频率或种类方面没有显著差异。总体而言,两组患者对美容效果都非常满意,两组间无显著差异。在肿瘤较大的患者中,采用肿瘤整形技术的保乳手术在主观肩部、手臂和乳房发病率以及美容效果方面与对较小肿瘤进行的 C-BCS 相当。ClinicalTrials.gov,注册号:NCT02159274(2014 年)。要点:与传统保乳手术相比,肿瘤整形保乳手术的肩部、手臂和乳房发病率的主观症状相当。肿瘤整形手术后肩部和手臂发病率的症状种类与传统保乳手术后的症状种类无差异。肿瘤整形保乳手术后的美容效果与无肿瘤整形技术的保乳手术相当。